Rationally engineered Cas9 nucleases with improved specificity
By I. Slaymaker, L. Gao, Bernd Zetsche, David A. Scott, Winston X. Yan, Feng Zhang. 2015
2,285 citations recorded by the source corpus.
Making the correct cut The CRISPR/Cas system is a prokaryotic immune system that targets and cuts out foreign DNA in bacteria. It has been adopted for gene editing because it can be designed to recognize and cut specific locations in the genome. A challenge in developing clinical applications is the potential for off-target effects that could result in DNA cleavage at the wrong locations. Slaymaker et al. used structure-guided engineering to improve the specificity of Streptococcus pyogenes Cas9 (SpCas9). They identified enhanced-specificity variants (eSpCas9) that display reduced off-target cleavage while maintaining robust on-target activity Science, this issue p. 84 Structure-guided engineering improves the genome editing specificity of the CRISPR-associated endonuclease Cas9. The RNA-guided endonuclease Cas9 is a versatile genome-editing tool with a broad range of applications from therapeutics to functional annotation of genes. Cas9 creates double-strand breaks (DSBs) at targeted genomic loci complementary to a short RNA guide. However, Cas9 can cleave off-target sites that are not fully complementary to the guide, which poses a major challenge for genome editing. Here, we use structure-guided protein engineering to improve the specificity of Streptococcus pyogenes Cas9 (SpCas9). Using targeted deep sequencing and unbiased whole-genome off-target analysis to assess Cas9-mediated DNA cleavage in human cells, we demonstrate that “enhanced specificity” SpCas9 (eSpCas9) variants reduce off-target effects and maintain robust on-target cleavage. Thus, eSpCas9 could be broadly useful for genome-editing applications requiring a high level of specificity.
Subfields: Business and International Management, Molecular Biology, Computational Biology & Bioinformatics
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Business and International Management
In Molecular Biology
- Feng Zhang
- Haifeng Wang
- Marie La Russa
- Lei S. Qi
- Eugene V. Koonin
- Kira S. Makarova
- Jennifer A. Doudna
- David R. Liu
In Computational Biology & Bioinformatics
- Alexander Rives
- C. Lawrence Zitnick
- Takanori Nakane
- Kira S. Makarova
- Rob Fergus
- Jay Shendure
- Eugene V. Koonin
- Jerry Ma
Citations in the corpus
- Biological structure and function emerge from scaling unsupervised learning to 250 million protein sequences (2019, background): “…mutational fitness landscape provides deep insight into biology: determining protein activity (Fowler & Fields, 2014), linking genetic variation to human health (Lek et al., 2016; Bycroft et al., 2018; Karczewski et al., 2019), and enabling for rational protein engineering (Slaymaker et al., 2016).”
- Evolved Cas9 variants with broad PAM compatibility and high DNA specificity (2018, positive): “These results, together with the success of multiple independent efforts to create high-fidelity Cas9 variants 26,36,37 , suggest that the DNA promiscuity of wild-type Cas9, which likely evolved to impede viral evasion, can readily be overcome by protein engineering or evolution.”
- Delivering CRISPR: a review of the challenges and approaches (2018, background): “Cas9 mutants have also been designed to reduce non-specific DNA contacts by weakening binding of 1240 C. A. LINO ET AL. the target DNA strand (Kleinstiver et al., 2016) or the non-target DNA strand (Slaymaker et al., 2016) to Cas9 while maintaining robust on-target cleavage.”
- Whole organism lineage tracing by combinatorial and cumulative genome editing (2016, background): “Finally, sgRNA sequences and lengths (31), Cas9 cleavage activity and target preferences (32,33), and themeansbywhichCas9 and sgRNA(s) are expressed [e.”
- CRISPR/Cas9 in Genome Editing and Beyond. (2016, methodology): “Different strategies have been developed to improve Sp Cas9 specificity: optimizing the sgRNA design (68, 142, 152); using paired nCas9s (5, 76–78), paired dCas9-FokI nucleases (153, 154) (Figure 1b), enhanced Sp Cas9 with improved specificity (155), shorter (17–18 bp) sgRNAs or sgRNAs with two unpa”